Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents (2013 - 2025)
Corbus Pharmaceuticals Holdings' Cash & Equivalents came in at $28.49 million for Q4 2025, up 65.7% from $17.2 million a year earlier and up 5.6% from the prior quarter.
Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents (2013 - 2025) Analysis & Trends
Going back to Q3 2013, Corbus Pharmaceuticals Holdings' Cash & Equivalents data covers 50 quarters.
- Cash & Equivalents carries a five-year compound annual growth rate of -19.7% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $17.2 million in FY2024 (+25.3%), $13.72 million in FY2023 (-19.3%), $17 million in FY2022 (-32.0%) and $25.01 million in FY2021 (-70.7%).
- The Q4 2025 figure represents the highest quarterly Cash & Equivalents since Q1 2022.
- Year-over-year, Cash & Equivalents increased in seven of the last eight quarters, with growth averaging 62.2%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2024 (growth of 183.7%), and the weakest in Q1 2023 (a decline of 87.2%).
- Business Quant data shows CRBP's Cash & Equivalents at $26.98 million (Q3 2025), $20.04 million (Q2 2025) and $18.9 million (Q1 2025) in the three quarters before Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 49.84 Mn | -466.79 Mn | - | 28.49 Mn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 28.49 Mn |
| Sep 30, 2025 | 26.98 Mn |
| Jun 30, 2025 | 20.04 Mn |
| Mar 31, 2025 | 18.90 Mn |
| Dec 31, 2024 | 17.20 Mn |
| Sep 30, 2024 | 19.42 Mn |
| Jun 30, 2024 | 23.69 Mn |
| Mar 31, 2024 | 14.10 Mn |
| Dec 31, 2023 | 13.72 Mn |
| Sep 30, 2023 | 11.25 Mn |
| Jun 30, 2023 | 8.35 Mn |
| Mar 31, 2023 | 7.32 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | 12.44 Mn |
| Jun 30, 2022 | 25.77 Mn |
| Mar 31, 2022 | 57.03 Mn |
| Dec 31, 2021 | 25.01 Mn |
| Sep 30, 2021 | 37.12 Mn |
| Jun 30, 2021 | 36.08 Mn |
| Mar 31, 2021 | 66.61 Mn |
Corbus Pharmaceuticals Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRBP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();